These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25562386)

  • 1. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
    Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
    Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
    Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells.
    Bekhite MM; González Delgado A; Menz F; Kretzschmar T; Wu JMF; Bekfani T; Nietzsche S; Wartenberg M; Westermann M; Greber B; Schulze PC
    Basic Res Cardiol; 2020 May; 115(4):37. PubMed ID: 32424548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.
    Sanchez-Freire V; Lee AS; Hu S; Abilez OJ; Liang P; Lan F; Huber BC; Ong SG; Hong WX; Huang M; Wu JC
    J Am Coll Cardiol; 2014 Aug; 64(5):436-48. PubMed ID: 25082575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
    Tang L; Wang H; Dai B; Wang X; Zhou D; Shen J; Guo F; Wang J; Zhou J; Wang H; Wu Q; Yao H; Gong T; Su J; Meng ZX; Niu T; Zhang L; Liang P
    J Mol Cell Cardiol; 2020 May; 142():53-64. PubMed ID: 32251671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Cultured Human Cardiomyocyte Clusters Obtained from Embryos/Fetuses or Derived from Human Embryonic Stem Cells.
    Grubb S; Vestergaard ML; Andersen AS; Rasmussen KK; Mamsen LS; Tuckute G; Grunnet-Lauridsen K; Møllgård K; Ernst E; Christensen ST; Calloe K; Andersen CY
    Stem Cells Dev; 2019 May; 28(9):608-619. PubMed ID: 30755084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in preclinical research on induced pluripotent stem cell therapy for acute myocardial infarction.
    Cai S; Dai Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 53(2):244-253. PubMed ID: 38594961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
    Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin.
    Lewandowski J; Rozwadowska N; Kolanowski TJ; Malcher A; Zimna A; Rugowska A; Fiedorowicz K; Łabędź W; Kubaszewski Ł; Chojnacka K; Bednarek-Rajewska K; Majewski P; Kurpisz M
    Cell Transplant; 2018 Jul; 27(7):1047-1067. PubMed ID: 29947252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.
    Cao N; Liu Z; Chen Z; Wang J; Chen T; Zhao X; Ma Y; Qin L; Kang J; Wei B; Wang L; Jin Y; Yang HT
    Cell Res; 2012 Jan; 22(1):219-36. PubMed ID: 22143566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes.
    Miller JM; Mardhekar NM; Pretorius D; Krishnamurthy P; Rajasekaran NS; Zhang J; Kannappan R
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H801-H815. PubMed ID: 32057252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
    Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
    Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
    Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
    Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
    Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
    Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
    Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.